resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on clinical pregnancy rate
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Furthermore, there were no significant differences detected between the resveratrol and placebo groups in terms of chemical pregnancy or clinical pregnancy rates (45.83% (11/24) vs. 33.33% (8/24); two-tailed P = 0.5556; 37.50% (9/24) vs. 29.17% (7/24); two-tailed P = 0.7601; Fig. 5).”
Quoted verbatim from Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial.. - Study
- RCT
- Duration
- 2 months
- Dose
- 800 mg/day (2 x 400 mg capsules) trans-resveratrol for 60 days before oocyte collection
- Population
- Women aged 18-35 with polycystic ovary syndrome undergoing ICSI; transfer cycles after oocyte retrieval
Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial.2024PMID:38987824Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Clinical pregnancy rate
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5RY004F7TRFV4GNAWTV10Z1